Drug misuse and dependency

Sign up for updates to this topic page

On this page

Services

1. NDTMS: community combined review forms

   Combined Review Forms (CRF) for community treatment services to use for Core Dataset P (CDS-P), from April 2020 onwards.

2. NDTMS: secure setting outcomes forms

   Outcome monitoring forms for use by secure setting from April 2020 for core dataset P.

See more services in this topic

Guidance and regulation

1. Controlled drugs list
   • Guidance
   • 2 December 2019
   • Home Office
2. COVID-19: guidance for commissioners and providers of services for people who use drugs or alcohol
   • Guidance
   • 31 July 2020
   • Department of Health and Social Care and Public Health England
3. Drug misuse and dependence: UK guidelines on clinical management
   • Guidance
   • 15 December 2017
   • Department of Health and Social Care
4. Independent review of drugs, part 2: terms of reference
   • Guidance
   • 2 July 2020
   • Department of Health and Social Care
5. Precursor chemical licensing
   • Detailed guide
   • 18 February 2020
   • Home Office

See more guidance and regulation in this topic

News and communications

3 August 2020 — News story

New appointments to the ACMD

Advisory Council on the Misuse of Drugs

1. Government launches second phase of independent review into drug misuse
   • 2 July 2020
   • Department of Health and Social Care
   • Press release
2. ACMD public evidence gathering: request for written evidence
   • 26 June 2020
   • Advisory Council on the Misuse of Drugs
   • News story
3. Circular 001/2020: Epidyolex scheduling, (SI) 2020 No. 559
   • 23 June 2020
   • Home Office
   • Correspondence
4. ACMD advice on administration rights for therapeutic radiographer independent prescribers
   • 22 April 2020
   • Advisory Council on the Misuse of Drugs
   • Correspondence

See more news and communications in this topic

Research and statistics

1. United Kingdom drug situation: Focal Point annual report
   • 31 July 2020
   • Home Office, Public Health England, Welsh Government, The Scottish Government, Public Health Wales, and Department of Health (Northern Ireland)
   • Research
2. Novel benzodiazepines: prevalence and harms in the UK
   • 29 April 2020
   • Advisory Council on the Misuse of Drugs
   • Research
3. Substance misuse treatment in secure settings: 2018 to 2019
   • 30 January 2020
   • Public Health England
   • Official statistics
4. Shooting Up: infections among people who inject drugs in the UK
   • 17 December 2019
   • Public Health England
   • Research
5. Substance misuse treatment for young people: statistics 2018 to 2019
   • 28 November 2019
   • Public Health England
   • National statistics

See more research and statistics in this topic

Policy papers and consultations

1. Independent review of drugs: call for evidence, part 2
   • 2 July 2020
   • Department of Health and Social Care
   • Closed consultation
   • Closing date 07 August 2020
2. NDTMS annual reports and methodology: proposed changes
   • 24 September 2019
   • Public Health England
   • Consultation outcome
   • Date closed 25 August 2019
3. ACMD ageing cohort of drug users report: government response
   • 3 October 2019
   • Department of Health and Social Care
   • Policy paper
4. Drug related harms in homeless populations: government response
   • 19 September 2019
   • Ministry of Housing, Communities & Local Government and Department of Health and Social Care
   • Policy paper
5. Drugs policy and medicinal cannabis report: government response
   • 6 September 2019
   • Department of Health and Social Care
   • Policy paper

See more policy papers and consultations in this topic

Transparency and freedom of information releases

1. Standard Operating Procedure for using evidence in ACMD reports
   • 26 March 2020
   • Advisory Council on the Misuse of Drugs
   • Corporate report
2. Commissioning impact on drug treatment
   • 6 September 2017
   • Advisory Council on the Misuse of Drugs
   • Corporate report
3. Drug strategy 2016: development review
   • 13 July 2017
   • Advisory Council on the Misuse of Drugs
   • Corporate report
4. Psychoactive Substances Bill: evaluation review
   • 13 July 2017
   • Advisory Council on the Misuse of Drugs
   • Corporate report
5. Methiopropamine: a review of the evidence of use and harm
   • 16 June 2017
   • Advisory Council on the Misuse of Drugs
   • Corporate report

See more transparency and freedom of information releases in this topic

Organisations

1. Home Office
2. Public Health England
3. Department of Health & Social Care
4. Department for Work & Pensions
5. Department for Transport

Show more organisations

1. Prime Minister's Office, 10 Downing Street
2. Foreign & Commonwealth Office
3. Ministry of Justice
4. Department for Digital, Culture, Media & Sport
5. Medicines & Healthcare products Regulatory Agency
6. Ministry of Housing, Communities & Local Government

1. Advisory Council on the Misuse of Drugs